237 related articles for article (PubMed ID: 24508556)
1. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
3. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
4. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
[No Abstract] [Full Text] [Related]
6. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
[TBL] [Abstract][Full Text] [Related]
7. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
Yeh YK; Ding JY; Ku CL; Chen WC
BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
[TBL] [Abstract][Full Text] [Related]
8. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases.
Hwang JH; Kim EJ; Koh WJ; Kim SY; Lee SH; Suh GY; Kwon OJ; Ki CS; Ji Y; Kang M; Kim DH
Tuberculosis (Edinb); 2007 Mar; 87(2):166-71. PubMed ID: 17023216
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
11. Beyond antibiotics for pulmonary nontuberculous mycobacterial disease.
Waterer G
Curr Opin Pulm Med; 2020 May; 26(3):260-266. PubMed ID: 32101903
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
13. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
[TBL] [Abstract][Full Text] [Related]
14. Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency.
Hallstrand TS; Ochs HD; Zhu Q; Liles WC
Eur Respir J; 2004 Sep; 24(3):367-70. PubMed ID: 15358692
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-interferon-gamma autoantibodies in subjects infected by Mycobacterium tuberculosis.
Madariaga L; Amurrio C; Martín G; García-Cebrian F; Bicandi J; Lardelli P; Suarez MD; Cisterna R
Int J Tuberc Lung Dis; 1998 Jan; 2(1):62-8. PubMed ID: 9562113
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
Albayrak N; Simşek H; Sezen F; Arslantürk A; Tarhan G; Ceyhan I
Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
[TBL] [Abstract][Full Text] [Related]
17. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
[TBL] [Abstract][Full Text] [Related]
18. NK Cell-Derived IFN-γ Protects against Nontuberculous Mycobacterial Lung Infection.
Lai HC; Chang CJ; Lin CS; Wu TR; Hsu YJ; Wu TS; Lu JJ; Martel J; Ojcius DM; Ku CL; Young JD; Lu CC
J Immunol; 2018 Sep; 201(5):1478-1490. PubMed ID: 30061197
[TBL] [Abstract][Full Text] [Related]
19. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
[TBL] [Abstract][Full Text] [Related]
20. Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.
Hwang JH; Koh WJ; Kim EJ; Kang EH; Suh GY; Chung MP; Kim H; Kwon OJ
Tuberculosis (Edinb); 2006 Sep; 86(5):382-5. PubMed ID: 16682253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
